$0.0190
+0 (+0%)
At Close: May 13, 2024
Expert Ratings for Invitae
07:06pm, Monday, 18'th Apr 2022 Benzinga
Over the past 3 months, 4 analysts have published their opinion on Invitae (NYSE:NVTA) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's
Invitae Pivots Towards Zero Cash-Burn
05:12am, Saturday, 16'th Apr 2022 Seeking Alpha
Invitae announced the intention to shift the focus from external capital-fueled growth to self-funding. Click to know how the company targets positive operating cash flow in the mid-term.
Invitae Pivots Towards Zero Cash-Burn
01:12am, Saturday, 16'th Apr 2022
Invitae announced the intention to shift the focus from external capital-fueled growth to self-funding. The company targets positive operating cash flow in the mid-term.
Clearbridge Small Cap Growth Strategy Portfolio Manager Commentary Q1 2022
04:23am, Friday, 15'th Apr 2022 Seeking Alpha
ClearBridge Small Cap Growth Strategy underperformed its index benchmark during Q1. Who were the leading detractors and contributors? Click here to find out.
ARKK: Cathie Wood's Secret Selling
03:10pm, Thursday, 31'st Mar 2022 Seeking Alpha
ARKK ETF has found a way to generate some fresh capital for purchases. Seven names have been sold but don't appear in the daily e-mail. See more on ARKK here.
2 Charts That Explain Invitae's Shortcomings
12:05pm, Wednesday, 30'th Mar 2022 The Motley Fool
Invitae is a leading genetic testing company that's been public since 2015. Why has the stock done so poorly?
Why Invitae Stock Rose 10.7% on Tuesday
07:50pm, Tuesday, 22'nd Mar 2022 The Motley Fool
The molecular diagnostics company is bouncing back from its two-year low.
Why Invitae Stock Rose 10.7% on Tuesday
03:50pm, Tuesday, 22'nd Mar 2022
The molecular diagnostics company is bouncing back from its two-year low.
Zacks Market Edge Highlights: Shopify, Block, PayPal, Skillz, and Invitae Corp
07:46am, Thursday, 17'th Mar 2022 Zacks Investment Research
Shopify, Block, PayPal, Skillz, and Invitae Corp are part of Today's Market Edge Blog.
Growth Stocks: Sell or Buy More?
06:35pm, Wednesday, 16'th Mar 2022 Zacks Investment Research
With some growth stocks down over 50% in 2022, what should investors do?
Growth Stocks: Sell or Buy More?
03:48pm, Wednesday, 16'th Mar 2022
With some growth stocks down over 50% in 2022, what should investors do?
Got $300? These 3 Stocks Could Be Bargain Buys for 2022 and Beyond
04:23pm, Wednesday, 09'th Mar 2022 The Motley Fool
There high-quality healthcare stocks are at fire-sale prices today.
Got $300? These 3 Stocks Could Be Bargain Buys for 2022 and Beyond
11:23am, Wednesday, 09'th Mar 2022
There high-quality healthcare stocks are at fire-sale prices today.
Invitae Corporation (NVTA) Presents at Cowen 42nd Annual Healthcare Conference (Transcript)
06:51pm, Monday, 07'th Mar 2022 Seeking AlphaInvitae Corporation (NVTA) Presents at Cowen 42nd Annual Healthcare Conference (Transcript)
01:51pm, Monday, 07'th Mar 2022
Invitae Corporation (NVTA) Presents at Cowen 42nd Annual Healthcare Conference (Transcript)
Sign In
Buy NVTA